title: Melanocortin signaling is decreased during neurotoxin-induced transient hyperphagia and increased body-weight gain.
abstract: Hypothalamic neuropeptides play critical roles in the regulation of feeding behavior and body weight (BW). Disruption of signaling in the ventromedial nucleus by microinjection of the neurotoxin, colchicine (COL), produces transient hyperphagia with corresponding BW gain lasting for 4 days. Because the melanocortin system exerts an inhibitory control on food intake, we hypothesized that hyperphagia in COL-treated rats is due to decreased melanocortin-induced restraint on feeding. Melanocortin restraint is exerted through alpha-melanocortin-stimulating hormone derived from proopiomelanocortin (POMC) and is antagonized by agouti-related peptide produced in neurons located in the arcuate nucleus (ARC). COL (4 microg/0.5 microl saline) or saline was microinjected bilaterally into the ventromedial nucleus of adult male rats. In conjunction with BW gain, blood leptin levels were elevated, whereas POMC mRNA in the ARC was significantly decreased in COL-injected rats. Levels of alpha-melanocortin-stimulating hormone were also decreased in the micropunched paraventricular nucleus, dorsomedial nucleus, and perifornical hypothalamus, sites implicated in the control of food intake. That diminution in melanocortin signaling underlies hyperphagia was supported by the observation that intracerebroventricular injection of the MC3/MC4 melanocortin receptor agonist, MTII, prevented the hyperphagia and BW gain. Surprisingly, however, mRNA levels of the orexigenic peptide agouti-related peptide in the ARC were decreased perhaps due to the action of elevated leptin. These results show that transient hyperphagia and BW gain induced by disruption of signaling in the ventromedial nucleus results from two neurochemical rearrangements: development of leptin resistance in POMC neurons and diminution in melanocortin signaling as reflected by decreased POMC gene expression in the ARC and decreased availability of alpha-melanocortin-stimulating hormone for release in feeding relevant sites.
authors.affiliation: Department of Physiology, University of Florida Brain Institute and College of Medicine, P.O. Box 100274, Gainesville, FL 32610, USA. mdube@ufl.edu
authors.forename: M G
authors.initials: MG
authors.lastname: Dube
authors.forename: S
authors.initials: S
authors.lastname: Pu
authors.forename: S P
authors.initials: SP
authors.lastname: Kalra
authors.forename: P S
authors.initials: PS
authors.lastname: Kalra
mesh_terms: D054369:Agouti-Related Protein; D000818:Animals; D003078:Colchicine / Q000494:pharmacology*; D006963:Hyperphagia / Q000188:drug therapy*; D036341:Intercellular Signaling Peptides and Proteins; D008297:Male; D008845:Microinjections; D009498:Neurotoxins / Q000494:pharmacology*; D009765:Obesity / Q000209:etiology; D011333:Pro-Opiomelanocortin / Q000378:metabolism*; D011506:Proteins / Q000235:genetics / Q000378:metabolism; D012333:RNA, Messenger / Q000032:analysis; D051381:Rats; D017207:Rats, Sprague-Dawley; D014697:Ventromedial Hypothalamic Nucleus / Q000187:drug effects*; D015430:Weight Gain / Q000187:drug effects*; D000521:alpha-MSH / Q000235:genetics / Q000378:metabolism
chemical_list: D054369:Agouti-Related Protein; D036341:Intercellular Signaling Peptides and Proteins; D009498:Neurotoxins; D011506:Proteins; D012333:RNA, Messenger; D000521:alpha-MSH; D011333:Pro-Opiomelanocortin; D003078:Colchicine